Today on DrugResearcher.com   F-star antibodies reaching for the sky Cellectricon delivers genome-wide RNAi screening system Marksman Cellject device automates zebrafish injection for drug screening Full potential of outsourcing to Asia yet to be grasped Drugs moving into the clinic: 27

Related Industry News   Micro-needles show they could be the better option Biogen dips toe in Indian waters Big biotech braces for biogeneric battle Pfizer blighted by Viracept scare

Breaking News on Drug Discovery
Daily  Wednesday 12 September 2007		Forward to a colleague

	Product Brochure A revolution in Sales Lead Generation! - Free Download Promote your products and technology towards our readers, and we'll build a detailed profile of each person who reads your presentation document... Download our FREE Smart Lead Generation brochure now!... Click Here Access Full Stories F-star antibodies reaching for the sky F-star is free to push forward with its plan to 'take antibody-based therapeutics to the next level' having secured venture capitalist backing... Read Cellectricon delivers genome-wide RNAi screening system Swedish cell-based screening expert Cellectricon has placed the world's first high throughput (HT) genome-wide RNAi screening system at a beta-test site for evaluation... Read Marksman Cellject device automates zebrafish injection for drug screening A group of Canadian scientists have developed a technique to automatically inject material such as DNA or experimental drugs into individual cells, to use in drug screening... Read Full potential of outsourcing to Asia yet to be grasped Outsourcing to Asia has become a common practice among the pharma industry but the trend has still some way to run, according to recently released market research... Read Drugs moving into the clinic: 27 The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read
	All News Headlines for: September | August | July
	Event Don't miss SMi's Drug Delivery Global Summit! This is a must-attend event for all those involved in addressing the growing challenges in the drug delivery field. The conference features an excellent opportunity to hear from an international panel of experts, including Bruce M Pratt, Vice President, Science Development, Genzyme... Click Here
	Related Industry News Micro-needles show they could be the better option A team of UK researchers have established micro-needles are a safer and less painful method for injections than the traditional hypodermic syringe... Read Biogen dips toe in Indian waters US-based biotech firm Biogen Idec has decided to enter the booming Indian market and establish its presence in the country... Read Big biotech braces for biogeneric battle The world's top two biotech firms are bracing themselves for heavy pressure from upcoming biogeneric competition, a new report has found... Read Pfizer blighted by Viracept scare It appears that pharma heavyweight Pfizer has not emerged unscathed from the contamination chaos that has affected EU supplies of HIV drug Viracept (nelfinavir), with the company this week warning that its version... Read Weekly comment Chinese scientists given freedom to fail As part of a drive towards greater innovation, the Chinese government looks set to introduce new laws giving its domestic scientists freedom to tackle complex scientific problems without fear of failure, according to a state media report this week. Read Previous Headlines Imaging protease activity US researchers have developed a molecular probe that can light up tumour cells within living animals and enable direct imaging of cysteine protease activity... Read AstraZeneca to help Biovator replace in vivo allergy testing AstraZeneca (AZ) is to assist Biovator in the development of its in vitro test for identifying potential allergens that could replace many experiments on animals... Read BioVascular, Revitus join forces to target vascular disease Two privately held biotech companies developing compounds to prevent blood clots have merged as their second drug candidate enters clinical trials... Read Second new class of HIV drug given thumbs up Merck & Co.'s integrase inhibitor, the first in a new class of HIV drug, looks likely to win approval in the near future, following a recommendation to regulators... Read MS drugs to drive Biogen long-term growth In a presentation to investors, Biogen Idec has announced it expects its MS drugs to fuel a 15 per cent annual growth in revenue in the next three years... Read Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com